Literature DB >> 22116946

Severe cutaneous adverse reactions to antiepileptic drugs in Asians.

C-Y Yang1, R-L Dao, T-J Lee, C-W Lu, C-H Yang, S-I Hung, W-H Chung.   

Abstract

OBJECTIVE: Ethnicity has been shown to be a contributing risk factor regarding antiepileptic drug (AED)-induced severe cutaneous adverse drug reactions (SCARs). To increase the clinical and epidemiologic information in Asians, we investigated the characteristics, outcome, and tolerability toward alternative drugs for AED-induced SCARs.
METHODS: A total of 154 patients with AED-induced SCARs, including Stevens-Johnson syndrome (SJS), toxic epidermal necrosis (TEN), and drug rash with eosinophilia and systemic symptoms (DRESS), were analyzed for demographic characteristics, causative AEDs, latent period, organ involvement, complications, and mortality. Tolerability toward alternative AEDs was followed for patients after AED-SCARs episodes.
RESULTS: Carbamazepine (CBZ) and phenytoin (PHT) were the most common causative AEDs for SJS/TEN (67.8%) and DRESS (43.6%), respectively. No SCARs case was caused by nonaromatic AEDs, e.g., valproic acid (VPA) and topiramate (TPM). The liver was the most frequently involved internal organ in AED-DRESS, whereas ocular complications were more commonly seen in AED-SJS/TEN. The mortality of AED-SJS/TEN and -DRESS was 6.1% and 7.7%, respectively. By following alternative AED usage of patients after AED-SCARs episodes, we noted that most patients were tolerant of nonaromatic AEDs. One case of oxcarbazepine-SJS had cross-hypersensitivity to lamotrigine (LTG) and further developed into DRESS.
CONCLUSION: CBZ, PHT, and LTG were the major causative AEDs for SCARs. The mortality of PHT-SCARs was higher than CBZ-SCARs due to complicated comorbidity in patients. Nonaromatic AEDs were safe alternatives for patients with aromatic AED-induced SCARs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116946     DOI: 10.1212/WNL.0b013e31823b478c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Is universal HLA-B*15:02 screening a cost-effective option in an ethnically diverse population? A case study of Malaysia.

Authors:  H Y Chong; Z Mohamed; L L Tan; D B C Wu; F H Shabaruddin; M Dahlui; Y D Apalasamy; S R Snyder; M S Williams; J Hao; L H Cavallari; N Chaiyakunapruk
Journal:  Br J Dermatol       Date:  2017-09-21       Impact factor: 9.302

Review 2.  Categorization and association analysis of risk factors for adverse drug events.

Authors:  Lina Zhou; Anamika Paul Rupa
Journal:  Eur J Clin Pharmacol       Date:  2017-12-08       Impact factor: 2.953

3.  Leukemoid reaction secondary to hypersensitivity syndrome to phenobarbital: a case report.

Authors:  Qinghai Zeng; Yuanqiang Wu; Yi Zhan; Ling Tang; Yangmei Zhou; Jun Yin; Fan Fan; Guiying Zhang; Qianjin Lu; Rong Xiao
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

Review 4.  Recent advances in the understanding of severe cutaneous adverse reactions.

Authors:  N R Adler; A K Aung; E N Ergen; J Trubiano; M S Y Goh; E J Phillips
Journal:  Br J Dermatol       Date:  2017-09-29       Impact factor: 9.302

5.  Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional analysis of patients in an integrated allergy repository of a large health care system.

Authors:  Kimberly G Blumenthal; Paige G Wickner; Jason J Lau; Li Zhou
Journal:  J Allergy Clin Immunol Pract       Date:  2014-11-18

6.  Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug Usage.

Authors:  Rosa Chan; Chun-Yu Wei; Yuan-Tsong Chen; Leslie Z Benet
Journal:  AAPS J       Date:  2016-03-07       Impact factor: 4.009

Review 7.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

8.  Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study.

Authors:  Ji Young Kim; Joongyub Lee; Young-Jin Ko; Ju-Young Shin; Sun-Young Jung; Nam-Kyong Choi; Byung-Joo Park
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 9.  Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions.

Authors:  Ali Fadhel Ahmed; Chonlaphat Sukasem; Majeed Arsheed Sabbah; Nur Fadhlina Musa; Dzul Azri Mohamed Noor; Nur Aizati Athirah Daud
Journal:  J Pers Med       Date:  2021-05-07

10.  Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin.

Authors:  Ponnusamy Santhamoorthy; K John Alexander; Asmahan Alshubaili
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.